Healthcare services firm Sevita is withdrawing a $2.5 billion leveraged loan sale, according to people familiar with the matter, the latest multibillion-dollar deal to be pulled as investors ramp up their scrutiny of borrowers.
Sevita is now weighing a revised sale in the loan and junk-bond markets in December, after it presents audited financial statements for the fiscal year ended Sept. 30 to prospective investors, said the people, who requested anonymity to discuss private deliberations.
A group of lenders led by
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.